Apixaban versus rivaroxaban in patients with atrial fibrillation and valvular heart disease: a population-based study: Annals of Internal Medicine: Vol 0, No 0

Memberships:

Center for Real-world Effectiveness and Safety of Therapeutics, Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine and Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania (GKD)

Department of Medicine and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA (AC)

Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan, Ann Arbor, Michigan (GDB)

Center for Real-world Effectiveness and Safety of Therapeutics, Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics, Epidemiology and Informatics, and Division of Gastroenterology and Hepatology, Perelman School of Medicine and Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia , Pennsylvania (JDL)

Center for Real-world Effectiveness and Safety of Therapeutics, Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics, Epidemiology and Informatics, and Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine and Leonard Davis Institute of Health Economics, University of Pennsylvania , Philadelphia, Pennsylvania (SH).

Grant assistance: By a National Institutes of Health Career Development Award (Grant K99HL159230).

Disclosures: The disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M22-0318.

Reproducible research statement: Study protocol and dataset: Unavailable. Statistics code: Available from Dr Dawwas (email, [email protected]upenn.educated).

Corresponding author: Ghadeer K. Dawwas, MSc, MBA, PhD, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, 423 Guardian Drive, Philadelphia, PA 19104-4865; E-mail, [email protected]upenn.educated.

Author’s contributions: Concept and design: GK Dawwas.

Data analysis and interpretation: A. Cuker, GK Dawwas, S. Hennessy, JD Lewis.

Editor of the article: GK Dawwas.

Critical review of article for significant intellectual content: GD Barnes, A. Cuker, GK Dawwas, S. Hennessy, JD Lewis.

Final article approval: GD Barnes, A. Cuker, GK Dawwas, S. Hennessy, JD Lewis.

Statistical expertise: GK Dawwas.

This article was published on Annals.org on October 18, 2022.

Comments are closed.